MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,972,958 | $4,775,000 | 1.26% |
Altium Capital Management LP | 1,250,000 | $3,025,000 | 0.79% |
Rubric Capital Management LP | 11,300,000 | $27,346,000 | 0.76% |
Vivo Capital, LLC | 6,907,189 | $16,715,000 | 0.75% |
DAFNA Capital Management LLC | 1,126,613 | $2,726,000 | 0.72% |
SILVERARC CAPITAL MANAGEMENT, LLC | 365,661 | $885,000 | 0.50% |
Orbimed Advisors | 17,264,764 | $41,781,000 | 0.46% |
Delphi Management Partners VIII, L.L.C. | 256,734 | $621,000 | 0.45% |
Endurant Capital Management LP | 746,514 | $1,807,000 | 0.41% |
Affinity Asset Advisors, LLC | 650,000 | $1,573,000 | 0.40% |